Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
108709567 | 10870956 | 7 | F | 2006 | 20160811 | 20150226 | 20160822 | EXP | PHHY2015BR022511 | NOVARTIS | 0.00 | F | Y | 61.00000 | KG | 20160822 | MD | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
108709567 | 10870956 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG (1 DF), QMO | Y | 21008 | 20 | MG | VIAL | /month | |||||
108709567 | 10870956 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG (1 DF), QMO (EVERY 28 DAYS) | Y | 21008 | 30 | MG | VIAL | /month | |||||
108709567 | 10870956 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 3 DF, QD | 0 | 3 | DF | TABLET | QD | ||||||
108709567 | 10870956 | 4 | C | SINVASTATINA | SIMVASTATIN | 1 | Oral | 1 DF, QHS | 0 | 1 | DF | TABLET | |||||||
108709567 | 10870956 | 5 | C | INSULIN | INSULIN NOS | 1 | Unknown | 72 U (42 UNITS IN THE MORNING AND 30 UNITS AT NIGHT) | 0 | 72 | DF |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
108709567 | 10870956 | 1 | Acromegaly |
108709567 | 10870956 | 3 | Diabetes mellitus |
108709567 | 10870956 | 4 | Product used for unknown indication |
108709567 | 10870956 | 5 | Diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
108709567 | 10870956 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
108709567 | 10870956 | Asthenia | |
108709567 | 10870956 | Blindness | |
108709567 | 10870956 | Crying | |
108709567 | 10870956 | Depressed mood | |
108709567 | 10870956 | Diabetes mellitus | |
108709567 | 10870956 | Fear | |
108709567 | 10870956 | Feeling abnormal | |
108709567 | 10870956 | Frustration tolerance decreased | |
108709567 | 10870956 | Gait disturbance | |
108709567 | 10870956 | Headache | |
108709567 | 10870956 | Hypoaesthesia | |
108709567 | 10870956 | Increased bronchial secretion | |
108709567 | 10870956 | Increased viscosity of upper respiratory secretion | |
108709567 | 10870956 | Insomnia | |
108709567 | 10870956 | Malaise | |
108709567 | 10870956 | Memory impairment | |
108709567 | 10870956 | Myalgia | |
108709567 | 10870956 | Nasal discharge discolouration | |
108709567 | 10870956 | Nasopharyngitis | |
108709567 | 10870956 | Neoplasm | |
108709567 | 10870956 | Pain in extremity | |
108709567 | 10870956 | Pyrexia | |
108709567 | 10870956 | Rhinorrhoea | |
108709567 | 10870956 | Swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
108709567 | 10870956 | 1 | 2005 | 201408 | 0 | |
108709567 | 10870956 | 2 | 201607 | 0 | ||
108709567 | 10870956 | 3 | 2005 | 0 | ||
108709567 | 10870956 | 4 | 2008 | 0 |